sr141716 has been researched along with Brain Ischemia in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (77.78) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, H; Reichenbach, ZW; Tuma, RF; Ward, SJ | 1 |
| Bagetta, G; Mannaioni, G; Pellegrini-Giampietro, DE | 1 |
| Chen, T; Fang, Y; Guo, J; Liao, H; Song, S; Sun, J; Yan, J; Zhang, L | 1 |
| Berger, C; Schabitz, WR; Schmid, HH; Schmid, PC; Schwab, S; Wolf, M | 1 |
| Braida, D; Guerini-Rocco, C; Pegorini, S; Sala, M; Zani, A | 1 |
| Bisogno, T; Di Marzo, V; Gessa, GL; Lutz, B; Marsicano, G; Melis, M; Minassi, A; Muntoni, AL; Perra, S; Petrosino, S; Pillolla, G; Pistis, M | 1 |
| Fernández-López, D; Lizasoain, I; Lorenzo, P; Martínez-Orgado, J; Moro, MA; Nuñez, E; Romero, J | 1 |
| Berger, C; Kuhnert, K; Müller, HD; Schäbitz, WR; Schomacher, M; Schwab, S; Sommer, C | 1 |
| Braida, D; Pozzi, M; Sala, M | 1 |
1 review(s) available for sr141716 and Brain Ischemia
| Article | Year |
|---|---|
Post-ischemic brain damage: the endocannabinoid system in the mechanisms of neuronal death.
Topics: Animals; Brain Injuries; Brain Ischemia; Cannabinoid Receptor Modulators; Cell Death; Disease Models, Animal; Endocannabinoids; Humans; Ischemic Attack, Transient; Isoenzymes; Neurons; Nitric Oxide Synthase; Piperidines; Pyrazoles; Rimonabant | 2009 |
8 other study(ies) available for sr141716 and Brain Ischemia
| Article | Year |
|---|---|
The CB1 antagonist, SR141716A, is protective in permanent photothrombotic cerebral ischemia.
Topics: Animals; Behavior, Animal; Body Weight; Brain; Brain Ischemia; Cannabinoid Receptor Antagonists; Disease Models, Animal; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Stroke | 2016 |
WIN55, 212-2 promotes differentiation of oligodendrocyte precursor cells and improve remyelination through regulation of the phosphorylation level of the ERK 1/2 via cannabinoid receptor 1 after stroke-induced demyelination.
Topics: Animals; Antimetabolites; Benzoxazines; Blotting, Western; Brain Ischemia; Bromodeoxyuridine; Cannabinoid Receptor Antagonists; Cell Differentiation; Cell Survival; Demyelinating Diseases; Immunohistochemistry; Indicators and Reagents; Male; MAP Kinase Signaling System; Microscopy, Electron; Morpholines; Myelin Basic Protein; Myelin Sheath; Naphthalenes; Oligodendroglia; Phosphorylation; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant; Stroke | 2013 |
Massive accumulation of N-acylethanolamines after stroke. Cell signalling in acute cerebral ischemia?
Topics: Acute Disease; Animals; Arachidonic Acids; Brain Ischemia; Cerebral Cortex; Corpus Striatum; Disease Models, Animal; Dizocilpine Maleate; Endocannabinoids; Ethanolamines; Excitatory Amino Acid Antagonists; Extracellular Fluid; Male; Microdialysis; Phospholipids; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptors, N-Methyl-D-Aspartate; Rimonabant; Signal Transduction; Stroke | 2004 |
Vanilloid VR1 receptor is involved in rimonabant-induced neuroprotection.
Topics: Animals; Avoidance Learning; Brain Ischemia; Cannabinoid Receptor Antagonists; Capsaicin; Electroencephalography; Gerbillinae; Male; Motor Activity; Neuroprotective Agents; Piperidines; Pyrazoles; Rimonabant; TRPV Cation Channels | 2006 |
Protective activation of the endocannabinoid system during ischemia in dopamine neurons.
Topics: Amidohydrolases; Animals; Arachidonic Acids; Benzoxazines; Brain Ischemia; Cannabinoid Receptor Modulators; Dopamine; Electrophysiology; Endocannabinoids; Glycerides; In Vitro Techniques; Male; Mice; Mice, Knockout; Morpholines; Naphthalenes; Neurons; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant; Signal Transduction; Ventral Tegmental Area | 2006 |
Characterization of the neuroprotective effect of the cannabinoid agonist WIN-55212 in an in vitro model of hypoxic-ischemic brain damage in newborn rats.
Topics: Anaerobiosis; Animals; Animals, Newborn; Arachidonic Acids; Benzoxazines; Brain; Brain Chemistry; Brain Ischemia; Cannabinoid Receptor Agonists; Cannabinoids; Disease Models, Animal; Hypoxia, Brain; L-Lactate Dehydrogenase; Morpholines; Naphthalenes; Neuroprotective Agents; Nitric Oxide Synthase Type II; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; Tumor Necrosis Factor-alpha | 2006 |
Neuroprotective cannabinoid receptor antagonist SR141716A prevents downregulation of excitotoxic NMDA receptors in the ischemic penumbra.
Topics: Animals; Autoradiography; Binding, Competitive; Brain Ischemia; Cyclohexanols; Dizocilpine Maleate; Down-Regulation; Excitatory Amino Acid Antagonists; Male; Neuroprotective Agents; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Rimonabant | 2006 |
CP 55,940 protects against ischemia-induced electroencephalographic flattening and hyperlocomotion in Mongolian gerbils.
Topics: Analgesics; Animals; Brain; Brain Ischemia; Cyclohexanols; Electroencephalography; Gerbillinae; Hyperkinesis; Male; Neuroprotective Agents; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Rimonabant | 2000 |